AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- 52-wk high
- $1,039.08
- 52-wk low
- $658.60
- Prev close
- $825.39
- Mkt cap
- $64.23B
- P/E
- 37.9x
- Fwd P/E
- 35.1x
Smart money
Earnings
Earnings came in 16.7% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.13B | $3.21B | $1.30B | $2.82B |
| Cost of what it sold | $109.4M | $339.9M | $121.0M | $279.3M |
| Gross profit | $1.02B | $2.87B | $1.18B | $2.54B |
| What it spent | ||||
| Research and development | $355.7M | $443.0M | $443.0M | $486.0M |
| Sales and admin | $336.3M | $422.5M | $355.0M | $532.5M |
| Other operating costs | $85.0M | $1.15B | $106.0M | $671.1M |
| Total operating expenses | $777.0M | $2.01B | $904.0M | $1.69B |
| What was left | ||||
| Operating profit | $350.0M | $850.8M | $394.0M | $846.8M |
| Interest on debt | $993.0K | $1.0M | $1.0M | $2.0M |
| Profit before tax | $386.1M | $991.7M | $426.0M | $958.9M |
| Tax | — | -$55.0M | — | $119.1M |
| Net profit | $344.3M | $1.05B | $366.0M | $838.8M |
| EBITDA | — | $1.01B | — | $863.8M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
11 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Resilient Argenx stock surges on Phase 3 autoimmune myositis success
BullishAug 17argenx SE Stock (ARGX) Moved Up by 16.67% on Aug 17: Drivers Behind the Movement
Leans bullishAug 17Why argenx Stock Has Surged on Monday
NeutralAug 17
